BLCO
Bausch + Lomb Corporation$15.10-0.20 (-1.28%)Prev Close$15.29·MCap$5.58B·P/E—·Vol171.6K·Yield—
▲
Buys (12M)
1
$71.0K
▼
Sells (12M)
6
$217.6K
◆
Net Activity
Net Seller
$146.6K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Bausch + Lomb Corporation (BLCO) has been dominated by selling, with 1 insider purchase totaling $71.0K and 6 insider sales totaling $217.6K. The most recent insider transaction was by Ling Karen (Director), who purchased $71.0K worth of shares on Feb 19, 2026. Bausch + Lomb Corporation operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $5.58B.
BLCO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Ling Karen | Director | Buy | 4,000 | $17.74 | $71.0K | 0 |
| Aug 5, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | Sell | 4,231 | $14.44 | $61.1K | 0 |
| Jul 25, 2025 | Bonnefoy Luc | President, Surgical | Sell | 2,167 | $14.32 | $31.0K | 0 |
| Jul 25, 2025 | Eldessouky Sam | EVP and CFO | Sell | 3,996 | $14.32 | $57.2K | 0 |
| Jul 25, 2025 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,841 | $14.32 | $40.7K | 0 |
| Jul 25, 2025 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,090 | $14.32 | $15.6K | 0 |
| Jun 13, 2025 | Bonnefoy Luc | President, Surgical | Sell | 968 | $12.33 | $11.9K | 0 |
| May 22, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | Buy | 22,000 | $11.28 | $248.1K | 0 |
| May 2, 2025 | VON ESCHENBACH ANDREW C. | Director | Buy | 1,695 | $11.76 | $19.9K | 0 |
| Apr 24, 2025 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 9,781 | $13.89 | $135.9K | 0 |
| Apr 24, 2025 | Stewart Andrew J. | See remarks | Sell | 3,954 | $13.89 | $54.9K | 0 |
| Feb 28, 2025 | Bonnefoy Luc | President,Surgical | Sell | 4,139 | $16.00 | $66.2K | 0 |
| Dec 23, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 4,402 | $17.83 | $78.5K | 0 |
| Dec 23, 2024 | Eldessouky Sam | EVP and CFO | Sell | 15,831 | $17.83 | $282.3K | 0 |
| Dec 23, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 5,075 | $17.83 | $90.5K | 0 |
| Dec 23, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 3,100 | $17.83 | $55.3K | 0 |
| Dec 23, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | Sell | 98,431 | $17.83 | $1.76M | 0 |
| Dec 23, 2024 | Stewart Andrew J. | See remarks | Sell | 2,524 | $17.83 | $45.0K | 0 |
| Aug 5, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | Buy | 32,250 | $15.66 | $505.1K | 0 |
| Jul 25, 2024 | Bonnefoy Luc | President,Surgical | Sell | 2,144 | $15.53 | $33.3K | 0 |
| Jul 25, 2024 | Eldessouky Sam | EVP and CFO | Sell | 5,113 | $15.53 | $79.4K | 0 |
| Jul 25, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,841 | $15.53 | $44.1K | 0 |
| Jul 25, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,313 | $15.53 | $20.4K | 0 |
| Jun 14, 2024 | Bonnefoy Luc | President,Surgical | Sell | 958 | $15.09 | $14.5K | 0 |
| Apr 24, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 9,838 | $14.90 | $146.6K | 0 |
| Apr 24, 2024 | Stewart Andrew J. | See remarks | Sell | 3,943 | $14.90 | $58.8K | 0 |
| Mar 1, 2024 | Bonnefoy Luc | President,Surgical | Sell | 1,098 | $16.47 | $18.1K | 0 |
| Mar 1, 2024 | Eldessouky Sam | EVP and CFO | Sell | 4,854 | $16.47 | $79.9K | 0 |
| Mar 1, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,143 | $16.47 | $35.3K | 0 |
| Mar 1, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 995 | $16.47 | $16.4K | 0 |
| Jul 25, 2023 | Bonnefoy Luc | President, Surgical | Sell | 2,240 | $19.82 | $44.4K | 0 |
| Jul 25, 2023 | Eldessouky Sam | EVP and CFO | Sell | 4,218 | $19.82 | $83.6K | 0 |
| Jul 25, 2023 | Hashad Yehia | EVP of R&D and CMO | Sell | 3,996 | $19.82 | $79.2K | 0 |
| Jul 25, 2023 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,313 | $19.82 | $26.0K | 0 |
| Apr 24, 2023 | Bernier Nathalie D. | Director | Sell | 227 | $17.12 | $3.9K | 0 |
| Apr 24, 2023 | ROBERTSON RUSSEL C | Director | Sell | 6,692 | $17.12 | $114.6K | 0 |
BLCO Insider Buying Activity
The following table shows recent insider purchases of Bausch + Lomb Corporation (BLCO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Ling Karen | Director | Buy | 4,000 | $17.74 | $71.0K | 0 |
| May 22, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | Buy | 22,000 | $11.28 | $248.1K | 0 |
| May 2, 2025 | VON ESCHENBACH ANDREW C. | Director | Buy | 1,695 | $11.76 | $19.9K | 0 |
| Aug 5, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | Buy | 32,250 | $15.66 | $505.1K | 0 |
BLCO Insider Selling Activity
The following table shows recent insider sales of Bausch + Lomb Corporation (BLCO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | SAUNDERS BRENT L | CEO and Chairman of the Board | Sell | 4,231 | $14.44 | $61.1K | 0 |
| Jul 25, 2025 | Bonnefoy Luc | President, Surgical | Sell | 2,167 | $14.32 | $31.0K | 0 |
| Jul 25, 2025 | Eldessouky Sam | EVP and CFO | Sell | 3,996 | $14.32 | $57.2K | 0 |
| Jul 25, 2025 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,841 | $14.32 | $40.7K | 0 |
| Jul 25, 2025 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,090 | $14.32 | $15.6K | 0 |
| Jun 13, 2025 | Bonnefoy Luc | President, Surgical | Sell | 968 | $12.33 | $11.9K | 0 |
| Apr 24, 2025 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 9,781 | $13.89 | $135.9K | 0 |
| Apr 24, 2025 | Stewart Andrew J. | See remarks | Sell | 3,954 | $13.89 | $54.9K | 0 |
| Feb 28, 2025 | Bonnefoy Luc | President,Surgical | Sell | 4,139 | $16.00 | $66.2K | 0 |
| Dec 23, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 4,402 | $17.83 | $78.5K | 0 |
| Dec 23, 2024 | Eldessouky Sam | EVP and CFO | Sell | 15,831 | $17.83 | $282.3K | 0 |
| Dec 23, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 5,075 | $17.83 | $90.5K | 0 |
| Dec 23, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 3,100 | $17.83 | $55.3K | 0 |
| Dec 23, 2024 | SAUNDERS BRENT L | CEO and Chairman of the Board | Sell | 98,431 | $17.83 | $1.76M | 0 |
| Dec 23, 2024 | Stewart Andrew J. | See remarks | Sell | 2,524 | $17.83 | $45.0K | 0 |
| Jul 25, 2024 | Bonnefoy Luc | President,Surgical | Sell | 2,144 | $15.53 | $33.3K | 0 |
| Jul 25, 2024 | Eldessouky Sam | EVP and CFO | Sell | 5,113 | $15.53 | $79.4K | 0 |
| Jul 25, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,841 | $15.53 | $44.1K | 0 |
| Jul 25, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,313 | $15.53 | $20.4K | 0 |
| Jun 14, 2024 | Bonnefoy Luc | President,Surgical | Sell | 958 | $15.09 | $14.5K | 0 |
| Apr 24, 2024 | Bailey A Robert D | EVP & Chief Legal Officer | Sell | 9,838 | $14.90 | $146.6K | 0 |
| Apr 24, 2024 | Stewart Andrew J. | See remarks | Sell | 3,943 | $14.90 | $58.8K | 0 |
| Mar 1, 2024 | Bonnefoy Luc | President,Surgical | Sell | 1,098 | $16.47 | $18.1K | 0 |
| Mar 1, 2024 | Eldessouky Sam | EVP and CFO | Sell | 4,854 | $16.47 | $79.9K | 0 |
| Mar 1, 2024 | Hashad Yehia | EVP of R&D and CMO | Sell | 2,143 | $16.47 | $35.3K | 0 |
| Mar 1, 2024 | Munsch Frederick | SVP, Controller and CAO | Sell | 995 | $16.47 | $16.4K | 0 |
| Jul 25, 2023 | Bonnefoy Luc | President, Surgical | Sell | 2,240 | $19.82 | $44.4K | 0 |
| Jul 25, 2023 | Eldessouky Sam | EVP and CFO | Sell | 4,218 | $19.82 | $83.6K | 0 |
| Jul 25, 2023 | Hashad Yehia | EVP of R&D and CMO | Sell | 3,996 | $19.82 | $79.2K | 0 |
| Jul 25, 2023 | Munsch Frederick | SVP, Controller and CAO | Sell | 1,313 | $19.82 | $26.0K | 0 |
| Apr 24, 2023 | Bernier Nathalie D. | Director | Sell | 227 | $17.12 | $3.9K | 0 |
| Apr 24, 2023 | ROBERTSON RUSSEL C | Director | Sell | 6,692 | $17.12 | $114.6K | 0 |
BLCO Insiders
Similar Stocks to BLCO
BDX
Becton, Dickinson and Company
$146.75-0.41%
$54.76B
MDLN
Medline Inc.
$36.55-1.55%
$28.42B
WST
West Pharmaceutical Services, Inc.
$327.72-0.79%
$22.59B
ATR
AptarGroup, Inc.
$117.46+0.75%
$7.40B
RGEN
Repligen Corporation
$131.87-1.10%
$7.34B
AVTR
Avantor, Inc.
$9.45-2.23%
$6.77B
MMSI
Merit Medical Systems, Inc.
$66.56-0.50%
$3.99B
ICUI
ICU Medical, Inc.
$142.67-0.13%
$3.57B